The root of many neurological and psychiatric conditions remains for the most part a medical mystery. Although pharmaceuticals have brought about some successes, paucity of treatment and its adverse effects in situations where the cause of the disease has not been fully understood remain unsettling. In some cases the long term effects of the medication can be worse than the condition itself.
Nobilis Therapeutics is developing proprietary inhalation-based treatments using controlled administration of inert gases that have exceptional safety profile proven by decades of clinical use.
By leveraging data on more than 500 patients successfully treated for conditions ranging from PTSD to autism, Nobilis has developed patent pending gas mixtures that offer reproducible, standardized, and controlled patient exposure, and are currently being advanced to address unmet medical need in psychiatric and neurological disorders.